FITC anti-mouse F4/80 Antibody

Pricing & Availability
Clone
BM8 (See other available formats)
Regulatory Status
RUO
Other Names
EMR1, Ly71
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
BM8_FITC_090707
Thioglycolate-elicited Balb/c mouse peritoneal macrophages stained with BM8 FITC
  • BM8_FITC_090707
    Thioglycolate-elicited Balb/c mouse peritoneal macrophages stained with BM8 FITC
See FITC spectral data
Cat # Size Price Quantity Avail. Save
123107 50 µg 44,00€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
123108 500 µg 124,00€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

F4/80 is a 160 kD glycoprotein. It is characterized as a member of the epidermal growth factor (EGF)-transmembrane 7 (TM7) family. F4/80, also known as EMR1 or Ly71, has been widely used as a murine macrophage marker, which is expressed on the majority of tissue macrophages including peritoneal macrophages, macrophages in lung, gut, thymus and red pulp of spleen (but not on the macrophages located in T cell areas of the spleen, lymph node and Peyer's patch), Kuffer cells, Langerhans cells, and bone marrow stromal cells. F4/80 has also been shown on a subset of dendritic cells. The biological ligand of F4/80 has not been identified, but it has been reported that F4/80 is required for induction of CD8+ T cells-mediated peripheral tolerance.

Product Details
Technical Data Sheet (pdf)

Product Details

Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Murine macrophages
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunohistochemical staining of acetone-fixed frozen sections1,2 and formalin-fixed paraffin-embedded sections6,7, and Western blotting.

Application References
  1. Schaller E, et al. 2002. Mol. Cell. Biol. 22:8035. (IHC)
  2. Stevceva L, et al. 2001. BMC Clin Pathol. 1:3. (IHC)
  3. Kobayashi M, et al.2008. J. Leukoc. Biol. 83:1354. PubMed
  4. Poeckel D, et al. 2009. J. Biol Chem. 284:21077. PubMed
  5. Glass AM, et al. 2013. J. Immunol. 190:4830. PubMed
  6. Koehm S, et al. 2007. J. Allergy Clin. Immunol. 120:570. (IHC)
  7. Rankin AL, et al. 2010. J. Immunol. 184:1526. (IHC)
  8. Sasi SP, et al. 2014. J Biol Chem. 289:14178. PubMed
  9. Thakus VS, et al. 2014. Toxicol Lett. 230:322. PubMed
  10. Watson NB, et al. 2015. J Immunol. 194:2796. PubMed
  11. Hirakawa H, et al. 2015. PLoS One. 10:119360. PubMed
Product Citations
  1. Taye B, et al. 2017. BMC Genomics . 10.1186/s12864-017-3803-6. PubMed
  2. Stubelius A, et al. 2017. Immunobiology. 10.1016/j.imbio.2017.05.007. PubMed
  3. Matsumoto K, et al. 2017. PLoS One. 12(6):e0175406. PubMed
  4. Nenasheva T, et al. 2017. PLoS One. 12(6):e0178983. PubMed
  5. Irie Y, et al. 2017. J Neuroimmune Pharmacol. 10.1007/s11481-017-9757-2. PubMed
  6. Dongsheng Z, et al. 2017. Inflammation. 10.1007/s10753-017-0619-0. PubMed
  7. Di G, et al. 2017. Invest Ophthalmol Vis Sci. 10.1167/iovs.17-21506. PubMed
  8. Lee Y, et al. 2017. PLoS One.. 10.1371/journal.pone.0183028. PubMed
  9. Kimura H, et al. 2017. J Immunol. 10.4049/jimmunol.1601798. PubMed
  10. Du H, et al. 2017. Nat Commun. 10.1038/s41467-017-00522-7. PubMed
  11. Yu Y, et al. 2018. Mol Med Rep. 17:8212. PubMed
  12. Zheng X, et al. 2018. J Clin Invest. 128:2104. PubMed
  13. Chen Y, et al. 2018. EBioMedicine. 32:31. PubMed
  14. Porrello A, et al. 2018. Nat Commun. 9:1988. PubMed
  15. Zhang Y, et al. 2018. Sci Rep. 8:5994. PubMed
  16. Nakazeki F, et al. 2018. Sci Rep. 8:8553. PubMed
  17. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  18. Proto JD et al. 2018. Immunity. 49(4):666-677 . PubMed
  19. Van Winkle JA et al. 2018. Cell host & microbe. 24(5):665-676 . PubMed
  20. Lancaster GI et al. 2018. Cell metabolism. 27(5):1096-1110 . PubMed
  21. Martínez‐López M et al. 2019. Immunity. 50(2):446-461 . PubMed
  22. Baomei Wang et al. 2019. Cell reports. 26(6):1614-1626 . PubMed
  23. Tavazoie MF, et al. 2018. Cell. 172:825. PubMed
  24. Bignami F, et al. 2017. Acta Ophthalmol. 95:e641. PubMed
  25. Wu W, et al. 2018. J Am Soc Nephrol. 29:168. PubMed
  26. Wang Y et al. 2017. Cell. 171(2):331-345 . PubMed
  27. Niknam S, et al. 2018. Clin Cancer Res. 24:5735. PubMed
  28. Subramanian K, et al. 2019. Nat Microbiol. 4:62. PubMed
  29. Barger SR, et al. 2019. Nat Commun. 10:1249. PubMed
  30. Albaghdadi AJH, et al. 2019. Sci Rep. 9:6528. PubMed
  31. Zhang S, et al. 2019. Mol Med Rep. 19:5377. PubMed
  32. Qiu X, et al. 2019. Theranostics. 9:2618. PubMed
  33. Kubli SP, et al. 2019. Nat Commun. 10:2678. PubMed
  34. Barry KC, et al. 2018. Nat Med. 24:1178. PubMed
  35. Lang JF et al. 2019. Nat Commun. 10(1):3415 . PubMed
  36. Tomay F, et al. 2019. J Transl Med. 17:237. PubMed
  37. Li B et al. 2019. Cell reports. 26(10):2720-2737 . PubMed
  38. Niemann J, et al. 2019. Nat Commun. 10:3236. PubMed
  39. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  40. Li A, et al. 2018. Cancer Lett. 431:54. PubMed
  41. Rashidi M, et al. 2019. J Immunol. 203:736. PubMed
  42. Li YT, et al. 2019. Elife. 8:e47642. PubMed
  43. Deniset JF et al. 2019. Immunity. 51(1):131-140 . PubMed
  44. Liu J, et al. 2019. Immunity. 50:600. PubMed
  45. An YA et al. 2017. eLife. 6 pii: e24071. PubMed
  46. Mouton AJ, et al. 2018. Basic Res Cardiol. 113:26:00. PubMed
  47. Wan X, et al. 2018. Nature. 560:107. PubMed
  48. Kurelac I, et al. 2019. J Clin Med. 1.85. PubMed
  49. Brunner JS, et al. 2020. Nat Commun. 0.757638889. PubMed
  50. Stifter SA, et al. 2019. Cell Rep. 29:3539. PubMed
  51. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  52. Krotova K, et al. 2019. Mol Ther Oncolytics. 15:166. PubMed
  53. Chou YJ, et al. 2020. Sci Rep. 10:8422. PubMed
  54. Kataru RP, et al. 2019. Cancer Immunol Res. 7:1345. PubMed
  55. Hsu SPC, et al. 2020. J Neurooncol. 146:417. PubMed
  56. Dan H, et al. 2020. Mol Oncol. 14:795. PubMed
  57. Xiong Y, et al. 2020. J Nanobiotechnology. 18:66. PubMed
  58. García-Bonilla M, et al. 2020. Stem Cell Res Ther. 11:121. PubMed
  59. Vazquez-Lombardi R, et al. 2017. Nat Commun. 8:15373. PubMed
  60. Zhang J, et al. 2020. J Cell Mol Med. 24:4547. PubMed
  61. Bhatia S, et al. 2019. Cancer Res. 79:2722. PubMed
  62. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  63. Caetano MS, et al. 2019. Clin Cancer Res. 25:7576. PubMed
  64. Niss K, et al. 2020. Cell Reports. 31(11):107763. PubMed
  65. Fukushima K, et al. 2020. Immunity. 52(3):542-556. PubMed
  66. Liu S, et al. 2020. Cell Host & Microbe. 26(6):779-794.e8.. PubMed
  67. Lu SW, et al. 2020. Nat Commun. 3.660416667. PubMed
  68. Yang W, et al. 2020. Nat Commun. 3.553472222. PubMed
  69. Coronel MM, et al. 2020. Sci Adv. 6:eaba5573. PubMed
  70. Nasser H, et al. 2020. Cell Death Discov. 0.29375. PubMed
  71. Moon H, et al. 2020. Nat Commun. 4.270138889. PubMed
  72. Wang L, et al. 2008. Cancer Res. 68:5639. PubMed
  73. Marcil A, et al. 2008. Infect Immun. 76:4345. PubMed
  74. Deng G, et al. 2010. J Immunol. 184:7154. PubMed
  75. Osorio K, et al. 2011. J Cell Biol. 193:235. PubMed
  76. Kasahara D, et al. 2012. J Immunol. 188:4558. PubMed
  77. Elias I, et al. 2012. Diabetes. 61:1801. PubMed
  78. Linde N, et al. 2012. PLoS One. 7:e40058. PubMed
  79. Jiang L, et al. 2013. Mol Immunol. 54:14. PubMed
  80. Miki Y, et al. 2013. J Exp Med. 210:1217. PubMed
  81. Bringmann G, et al. 2013. Antimicrob Agents Chemother. 57:3003. PubMed
  82. Quick M, et al. 2012. Am J Physiol Regul Integr Comp Physiol. 303:580. PubMed
  83. Odkhuu E, et al. 2014. Innate Immunity. 21:194. PubMed
  84. Richardson M, et al. 2014. PLoS Negl Trop Dis. 8:2825. PubMed
  85. Suo J, et al. 2014. J Leukoc Biol. 96:133. PubMed
  86. Wegiel B, et al. 2014. Cell Death Dis. 5:1139. PubMed
  87. Zhao X, et al. 2014. J Biol Chem. 289:30052. PubMed
  88. Drori A, et al. 2014. PLoS One. 9:110942. PubMed
  89. Torres I, et al. 2014. Infect Immun . 82:4689. PubMed
  90. Honda H, et al. 2014. J Leukoc Biol. 96:1087. PubMed
  91. Xiao Z, et al. 2015. Cancer Lett. 360:302. PubMed
  92. Sasaki Y, et al. 2015. PLoS One. 10: 0131176. PubMed
  93. Vettorazzi S, et al. 2015. Nat Commun. 6: 7796. PubMed
  94. Schaffert S, et al. 2015. J Immunol. 195: 1470-1479. PubMed
  95. Meunier I, et al. 2015. PLoS One. 10: 0138055. PubMed
  96. Arce-Cerezo A, et al. 2015. Sci Rep. 5: 1448. PubMed
  97. Patankar Y, et al. 2015. Am J Physiol Lung Cell Mol Physiol. 309: L902 - L913. PubMed
  98. Uematsu T, et al. 2015. Sci Rep. 5: 17577. PubMed
  99. Ohtsuki T, et al. 2016. J Virol. 90: 300 - 307. PubMed
  100. Chen Z, et al. 2016. PLoS One. 11: 0146681. PubMed
  101. Zheng M, et al. 2016. Sci Rep. 6:28729. PubMed
  102. Kwon H, Kim S 2016. Cell Death Dis. 7:22285. PubMed
  103. Artz A, Butz S, Vestweber D 2016. Am J Physiol Renal Physiol. 311: F176 - F181. PubMed
  104. Mothes B, et al. 2016. PLoS One. 11: 0159310. PubMed
  105. Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed
  106. Martins R, et al. 2016. Nat Immunol. 17:1361-1372. PubMed
  107. Velázquez K, et al. 2016. Am J Physiol Gastrointest Liver Physiol. 311: G699 - G712. PubMed
  108. Uematsu T, et al. 2016. Sci Rep. 6:37815. PubMed
  109. van Aalst S, et al. 2017. Vaccine. 10.1016/j.vaccine.2017.02.005. PubMed
  110. Parayath NN, et al. 2020. Nat Commun. 4.680555556. PubMed
  111. Barsoumian HB, et al. 2020. J Immunother Cancer. 8:00. PubMed
  112. Simoni L, et al. 2020. Cell Rep. 33:108330. PubMed
  113. Zhou T, et al. 2021. Bioact Mater. 0.734027778. PubMed
  114. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  115. Cortez MA, et al. 2020. Nat Commun. 3.819444444. PubMed
  116. Yuan Y, et al. 2020. Front Physiol. 0.967361111. PubMed
  117. Bordas M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  118. Vaibhav K, et al. 2020. Sci Adv. 6:eaax8847. PubMed
  119. Lv JJ, et al. 2021. Front Cell Dev Biol. 8:609090. PubMed
  120. Yan T, et al. 2021. Toxicological Sciences. 181(2):273-284. PubMed
  121. Hou PP, et al. 2020. Molecular Cell. 78(6):1192-1206.e10. PubMed
  122. Tran S, et al. 2020. Immunity. 53(3):627-640.e5. PubMed
  123. Liu K, et al. 2021. Cell Metabolism. 33(3):666-675.e4. PubMed
  124. Omori S, et al. 2021. Cell Reports. 34(6):108734. PubMed
  125. DeVito NC, et al. 2021. Cell Reports. 35(5):109071. PubMed
  126. Ratitong B, et al. 2021. Cell Reports. 35(7):109139. PubMed
RRID
AB_893500 (BioLegend Cat. No. 123107)
AB_893502 (BioLegend Cat. No. 123108)

Antigen Details

Structure
EGF-TM7 family member, 160 kD glycoprotein
Distribution

Majority of tissue macrophages including peritoneal macrophages, macrophages in lung, gut, thymus and red pulp of spleen, Kuffer cells, Langerhans cells, bone marrow stromal cells, and a subset of dendritic cells

Function
Induction of immunological tolerance
Cell Type
Dendritic cells, Langerhans cells, Macrophages, Tregs
Biology Area
Cell Biology, Immunology, Innate Immunity, Neuroinflammation, Neuroscience
Antigen References

1. Austy JM and Gordon S. 1981. Eur. J. Immunol. 11:805.
2. Hume DA, et al. 1983. J. Exp. Med. 158:1522.
3. Ruedl C, et al. 1996. Eur. J. Immunol. 26:1801.
4. McKnight AJ, et al. 1996. J. Biol. Chem. 271:486.
5. Lin HH, et al. 2005. J. Exp. Med. 201:1615.

Gene ID
13733 View all products for this Gene ID
UniProt
View information about F4/80 on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 2    Revision Date: 10-25-2013

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Insert Note Here
Save Close Clear
Lab Timer
Tools
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account